Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Caseinolytic protease P1/P2 complex (ClpP1/P2) is an essential, ATP-dependent serine protease system found in Mycobacterium tuberculosis (Mtb). Unlike most bacteria that utilize a single ClpP homooligomer, Mtb requires a heterotetradecameric complex consisting of two distinct heptameric rings, ClpP1 and ClpP2, which must associate to become catalytically active (Akopian et al., 2012, Nature). This complex plays a vital role in bacterial proteostasis by degrading misfolded or damaged proteins, a process necessary for Mtb survival during both active growth and dormant phases of infection (Famulla et al., 2016, Molecular Microbiology). Because ClpP1/P2 is vital for Mtb viability and lacks a direct functional equivalent in the human cytosol, it has become a high-priority target for the development of next-generation antitubercular agents. Small molecules such as acyldepsipeptides (ADEPs) can bind to the complex and cause it to undergo uncontrolled proteolysis, effectively leading to bacterial self-digestion, while other molecules like lassomycin act as potent inhibitors by blocking the interaction with regulatory ATPases (Gavrish et al., 2014, Chemistry & Biology; Chou et al., 2014, JACS).
Dysregulation of proteolytic activity via allosteric activation (leading to uncontrolled degradation) or direct inhibition of the proteolytic core.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caseinolytic protease P1/P2 complex (ClpP1/P2).